Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

A test for nail fungus was most accurate with PAS stain, low-dose spironolactone helped two-thirds of acne patients, metformin reduced symptoms of HIV-related fat distribution changes with some side effects, and skin examination with dermoscopy was better at detecting abnormal moles, while temporary tattoos can cause skin reactions.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Excess androgens may cause PCOS, not just be a symptom.

Astressin-B can reverse and prevent hair loss in stressed mice.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Polycystic ovary syndrome causes chronic inflammation affecting all body systems, but proper nutrition, exercise, and supplements can improve the condition.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.